scholarly journals Regulated Expression of pH Sensing G Protein-Coupled Receptor-68 Identified through Chemical Biology Defines a New Drug Target for Ischemic Heart Disease

2012 ◽  
Vol 7 (6) ◽  
pp. 1077-1083 ◽  
Author(s):  
Jamie L. Russell ◽  
Sean C. Goetsch ◽  
Hector R. Aguilar ◽  
Helen Coe ◽  
Xiang Luo ◽  
...  
2018 ◽  
Vol 32 (S1) ◽  
Author(s):  
Lauren Therese May ◽  
Jo‐Anne Baltos ◽  
Chung H. Chuo ◽  
Elizabeth A. Vecchio ◽  
Bing H. Wang ◽  
...  

2006 ◽  
Vol 27 (4) ◽  
pp. 1334-1347 ◽  
Author(s):  
Li V. Yang ◽  
Caius G. Radu ◽  
Meenakshi Roy ◽  
Sunyoung Lee ◽  
Jami McLaughlin ◽  
...  

ABSTRACT GPR4 is a G protein-coupled receptor expressed in the vasculature, lung, kidney, and other tissues. In vitro ectopic overexpression studies implicated GPR4 in sensing extracellular pH changes leading to cyclic AMP (cAMP) production. To investigate its biological roles in vivo, we generated GPR4-deficient mice by homologous recombination. Whereas GPR4-null adult mice appeared phenotypically normal, neonates showed a higher frequency of perinatal mortality. The average litter size from GPR4−/− intercrosses was ∼30% smaller than that from GPR4+/+ intercrosses on N3 and N5 C57BL/6 genetic backgrounds. A fraction of knockout embryos and neonates had spontaneous hemorrhages, dilated and tortuous subcutaneous blood vessels, and defective vascular smooth muscle cell coverage. Mesangial cells in kidney glomeruli were also significantly reduced in GPR4-null neonates. Some neonates exhibited respiratory distress with airway lining cell metaplasia. To examine whether GPR4 is functionally involved in vascular pH sensing, an ex vivo aortic ring assay was used under defined pH conditions. Compared to wild-type aortas, microvessel outgrowth from GPR4-null aortas was less inhibited by acidic extracellular pH. Treatment with an analog of cAMP, a downstream effector of GPR4, abolished microvessel outgrowth bypassing the GPR4-knockout phenotype. These results suggest that GPR4 deficiency leads to partially penetrant vascular abnormalities during development and that this receptor functions in blood vessel pH sensing.


2012 ◽  
Vol 111 (9) ◽  
pp. 1222-1236 ◽  
Author(s):  
Andrew M. Walters ◽  
George A. Porter ◽  
Paul S. Brookes

2016 ◽  
Vol 2 (6) ◽  
pp. 796-810 ◽  
Author(s):  
Cheryl de Vallière ◽  
Jesus Cosin-Roger ◽  
Simona Simmen ◽  
Kirstin Atrott ◽  
Hassan Melhem ◽  
...  

2017 ◽  
Vol 152 (5) ◽  
pp. S758-S759
Author(s):  
Irina Tcymbarevich ◽  
Nicole M. Obialo ◽  
Jesus Cosin-Roger ◽  
Klaus Seuwen ◽  
Gerhard Rogler ◽  
...  

2017 ◽  
Vol 11 (suppl_1) ◽  
pp. S113-S113
Author(s):  
I. Tcymbarevich ◽  
N. Obialo ◽  
J. Cosin-Roger ◽  
K. Seuwen ◽  
G. Rogler ◽  
...  

2013 ◽  
Vol 12 (11) ◽  
pp. 1433-1438 ◽  
Author(s):  
Matthew T. Brewer ◽  
Prince N. Agbedanu ◽  
Mostafa Zamanian ◽  
Tim A. Day ◽  
Steve A. Carlson

ABSTRACT Entamoeba histolytica is the causative agent of amoebic dysentery, a worldwide protozoal disease that results in approximately 100,000 deaths annually. The virulence of E. histolytica may be due to interactions with the host bacterial flora, whereby trophozoites engulf colonic bacteria as a nutrient source. The engulfment process depends on trophozoite recognition of bacterial epitopes that activate phagocytosis pathways. E. histolytica GPCR-1 (EhGPCR-1) was previously recognized as a putative G-protein-coupled receptor (GPCR) used by Entamoeba histolytica during phagocytosis. In the present study, we attempted to characterize EhGPCR-1 by using heterologous GPCR expression in Saccharomyces cerevisiae . We discovered that bacterial lipopolysaccharide (LPS) is an activator of EhGPCR-1 and that LPS stimulates EhGPCR-1 in a concentration-dependent manner. Additionally, we demonstrated that Entamoeba histolytica prefers to engulf bacteria with intact LPS and that this engulfment process is sensitive to suramin, which prevents the interactions of GPCRs and G-proteins. Thus, EhGPCR-1 is an LPS-recognizing GPCR that is a potential drug target for treatment of amoebiasis, especially considering the well-established drug targeting to GPCRs.


Sign in / Sign up

Export Citation Format

Share Document